Made Scientific and Streamline Bio Launch Exclusive Early Adopter Program to Advance AI-Driven Cell Therapy Manufacturing

11 February 2026 | News

The partnership integrates Streamline Bio’s autonomous robotics platform into a GMP-ready environment to accelerate scalable, automated CAR-T and cell therapy production.

Subscribe to our newsletter

Monthly digest of what's new and exciting from us.

We'll never share your email with anyone else.